News
-
-
COMMUNIQUÉ DE PRESSE
Immunic, Inc. to Participate in Investor Conference in December
Immunic, Inc. to Participate in Investor Conference in December. Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing therapies for chronic inflammatory and autoimmune diseases, announces participation in Piper Sandler 36th Annual Healthcare Conference in New York -
-
-
COMMUNIQUÉ DE PRESSE
Healthcare specialist SHS Capital acquires majority stake in Medizintechnik Rostock GmbH (MTR), a leading home care provider of medical devices in Germany
SHS Capital acquires majority stake in leading German home care provider MTR, specializing in medical therapy devices for movement, electro, and compression therapy, to support nationwide expansion -
-
COMMUNIQUÉ DE PRESSE
Chow Tai Fook Jewellery Reports Resilient Operating Profit as it Grows to HK$6.8 billion in 1HFY2025 Amid Challenging Market Environment
Chow Tai Fook Jewellery Group Limited announces 1HFY2025 results with operating profit growing 4.0% amid revenue decline. Brand transformation and strategic priorities key focus for sustainable growth -
COMMUNIQUÉ DE PRESSE
Chow Tai Fook Jewellery Reports Resilient Operating Profit as it Grows to HK$6.8 billion in 1HFY2025 Amid Challenging Market Environment
Chow Tai Fook Jewellery Group announces resilient operating profitability with 4.0% growth in operating profit and proposed share buy-back plan amid challenging market environment in 1HFY2025 -
COMMUNIQUÉ DE PRESSE
Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer
Zentiva AG, a subsidiary of Zentiva Pharma GmbH, secures approx. 85.27% of APONTIS PHARMA AG voting rights in a successful public purchase offer, aiming to enhance medicine delivery capabilities -
